Time to Prerandomization Seizure Count Design Sufficiently Assessed the Safety and Tolerability of Perampanel for the Treatment of Focal Seizures

A Modern Design for a Phase 2/3 Randomized, Double-blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of BHV-7000 in Idiopathic Generalized Epilepsy with Generalized Tonic-Clonic Seizures